Skip to content

The DNAnexus Next-Gen Therapeutics Accelerator

Industrialize your translational medicine workflows and transform bespoke analysis into a repeatable factory.

Collaboration-Black

The Need

The pharmaceutical industry is facing an R&D productivity crisis, where a $1.4B sunk cost for a Phase III failure is an existential threat. The primary driver of failure is the 'Translational Chasm'—the inability to connect lab-side omics data to clinic-side patient outcomes.

Clinical Trials-Black

Use Case

The ADC Rescue Mission

Following a $40B acquisition of an Antibody-Drug Conjugate (ADC) asset, a pharmaceutical company finds legacy genomics, clinical results, and digital pathology scans locked in incompatible silos. They leverage the Next-Gen Therapeutics Accelerator for enterprise-grade data ingestion, harmonization, cohorting, and AI tooling.

Through this unified translational factory, the team identifies a novel biomarker signature that predicts treatment responders with 30% greater accuracy, validating the acquisition to the Board.

Genomics Analysis-Black

Our Solution

The Next-Gen Therapeutics Accelerator industrializes your translational workflows, turning bespoke analysis into a repeatable factory. This bundle leverages:

  • The Cohort Browser: A unified interface to explore multimodal data. Stratify patients by combining clinical phenotypes with molecular biomarkers to define precise trial cohorts.

  • An Automated Ingestion Layer: Standardized ingestion workflows that harmonize data from disparate vendors and assays into a consistent format, eliminating manual cleaning.

  • Asset-Ready Data Rooms: Secure, governed workspaces designed for external collaboration. Safely ingest partner data (CROs, academic partners) without uncontrolled file transfers.

  • AI/ML Accelerator: Advanced tooling for biomarker discovery, enabling teams to build rigorous ranking models for target identification 2x faster.

  • GxP + Omics Data Catalog (ODC): A pre-validated environment to cut FDA/EMA submission preparation time by 6 months.
Next-gen Therapeutics

Interested in learning more about The Next-Gen Therapeutics Accelerator?

Your Key Benefits and Outcomes

  • Reproducible Science: Move from ad hoc, 'one-off' analyses to consistent, versioned pipelines.

  • Faster Collaboration: Spin up secure data rooms for partners in days, not months.

  • Unified Stratification: Define complex patient cohorts once and reuse the logic across multiple trial phases.
Coworkers sitting together and smiling outside.

We can help you achieve your goals. Start the process with a brief scientific consultation to determine how we can help.